• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,188.65 -78.69
( -0.11%)
Global Indices
Nasdaq
51,095.09 41.63
(0.08%)
Dow Jones
7,620.62 19.56
(0.26%)
Hang Seng
67,130.34 800.84
(1.21%)
Nikkei 225
10,313.41 -95.87
(-0.92%)
Forex
USD-INR
94.75 -1.18
(-1.23%)
EUR-INR
110.47 -1.07
(-0.96%)
GBP-INR
127.45 -1.26
(-0.98%)
JPY-INR
0.59 -0.01
(-1.17%)

EQUITY - MARKET SCREENER

Sanofi Consumer Healthcare India Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
544250
INE0UOS01011
166.747829
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SANOFICONR
41.76
10558.27
EPS(TTM)
Face Value()
Div & Yield %
109.78
10
0
 

haryana capfin ltd
Hindustan Unilever board OKs Rs 2,000-cr capex for capacity expansion
Feb 19,2026
The proposed investment is in line with the company’s strategy of focusing on fewer, bigger bets and strengthening its presence in high-growth demand spaces, including premium skin care and hair care and personal care & home care liquids.

Priya Nair, CEO and managing director, HUL, said: 'This investment reflects our strategic focus on scaling our brands and creating categories of the future to meet evolving consumer needs. It also underscores our commitment to building a resilient, technology-enabled supply chain that delivers superior value to consumers.'

Hindustan Unilever is in the FMCG business comprising primarily of Home Care, Beauty & Personal Care and Foods & Refreshment segments. The Company has manufacturing facilities across the country and sells primarily in India.

The company's consolidated net profit zoomed 120.91% to Rs 6,603 crore on 5.74% jump in revenue from operations to Rs 16,235 crore in Q3 FY26 over Q3 FY25.

The counter fell 1.90% to end at Rs 2279.50 on the BSE.